切换至 "中华医学电子期刊资源库"

中华诊断学电子杂志 ›› 2017, Vol. 05 ›› Issue (04) : 235 -239. doi: 10.3877/cma.j.issn.2095-655X.2017.04.005

所属专题: 文献

心脑血管疾病诊治

动脉钙化发生机制的研究进展
张雪1, 孟强2, 孙琳2,()   
  1. 1. 272067 济宁医学院
    2. 272029 济宁医学院附属医院内分泌科
  • 收稿日期:2017-05-05 出版日期:2017-11-26
  • 通信作者: 孙琳
  • 基金资助:
    山东省自然科学基金联合专项计划(ZR2014HL031)

The research progress of the mechanism of arterial calcification

Xue Zhang1, Qiang Meng2, Lin Sun2,()   

  1. 1. Jining Medical University, Jining 272067, China
    2. Department of Endocrinology, the Affiliated Hospital of Jining Medical University, Jinning 272029, China
  • Received:2017-05-05 Published:2017-11-26
  • Corresponding author: Lin Sun
  • About author:
    Corresponding author: Sun Lin, Email:
引用本文:

张雪, 孟强, 孙琳. 动脉钙化发生机制的研究进展[J]. 中华诊断学电子杂志, 2017, 05(04): 235-239.

Xue Zhang, Qiang Meng, Lin Sun. The research progress of the mechanism of arterial calcification[J]. Chinese Journal of Diagnostics(Electronic Edition), 2017, 05(04): 235-239.

动脉钙化常见于动脉粥样硬化、糖尿病、老年人及慢性肾脏病患者,是导致心血管疾病发生发展和致死的重要原因。目前认为,动脉钙化是一种类似于骨形成的主动调控过程,其中血管平滑肌细胞(VSMCs)是动脉钙化的细胞学基础。然而,动脉钙化的确切机制尚不清楚,多种因素如C反应蛋白(CRP)、骨形成蛋白(BMPs)、核苷酸结合寡聚化结构域样受体3(NLRP3)以及骨保护素(OPG)等都影响其进程。笔者简要综述了炎症、细胞因子和相关免疫与动脉钙化的关系。

Vascular calcification is prevalent in patients with atherosclerosis, old age, diabetes mellitus, and chronic kidney diseases.It is highly associated with increased morbidity and mortality of cardiovascular diseases.At present, arterial calcification is a kind of active regulation process similar to bone formation, in which vascular smooth muscle cells are the cytological basis.However, the exact mechanism of arterial calcification is not clear, a variety of factors such as C-reactive protein, bone morphogenetic proteins, NLRP3 inflammatory body and osteoprotegerin and so on can affect its progress.This paper briefly reviews the relationship among inflammation, cytokines and related immunity with arterial calcification.

[1]
Makarovic' SZ,Makarović R,Steiner, et al.Osteoprotegerin and vascular calcification:clinical and prognostic relevance[J]. Coll Antropol, 2015, 39(2): 461-468.
[2]
Wen C,Yang X,Yan Z, et al.Nalp3 inflammasome is activated and required for vascular smooth muscle cell calcification[J]. Int J Cardiol, 2013, 168(3): 2242-2247.
[3]
New SE,Aikawa E. Cardiovascular calcification:an inflammatory disease[J]. Circ J, 2011, 75(6): 1305-1313.
[4]
Al-Aly Z. Medial vascular calcification in diabetes mellitus and chronic kidney disease:the role of inflammation[J]. Cardiovasc Hematol Disord Drug Targets, 2007, 7(1): 1-6.
[5]
Wang AY,Lam CW,Wang M, et al.Increased circulating inflammatory proteins predict a worse prognosis with valvular calcification in end-stage renal disease:a prospective cohort study[J]. Am J Nephrol, 2008, 28(4): 647-653.
[6]
Kiu Weber CI,Duchateau-Nguyen G,Solier C, et al.Cardiovascular risk markers associated with arterial calcification in patients with chronic kidney disease Stages 3 and 4[J]. Clin Kidney J, 2014, 7(2): 167-173.
[7]
Hjortnaes J,Butcher J,Figueiredo JL, et al.Arterial and aortic valve calcification inversely correlates with osteoporotic bone remodelling:a role for inflammation[J]. Eur Heart J, 2010, 31(16): 1975-1984.
[8]
陈秀鹃,孙琳,张正军, 等. 长链非编码RNA-ANCR对小鼠血管平滑肌细胞成骨样分化的影响[J]. 中华骨质疏松和骨矿盐疾病杂志, 2017(03): 252-259.
[9]
Fantus D,Awan Z,Seidah NG, et al.Aortic calcification: Novel insights from familial hypercholesterolemia and potential role for the low-density lipoprotein receptor[J]. Atherosclerosis, 2013, 226(1): 9-15.
[10]
Parhami F,Basseri B,Hwang J, et al.High-density lipoprotein regulates calcification of vascular cells[J]. Circ Res, 2002, 91(7): 570-576.
[11]
Callegari A,Coons ML,Ricks JL, et al.Increased calcification in osteoprotegerin-deficient smooth muscle cells:Dependence on receptor activator of NF-kappaB ligand and interleukin 6[J]. J Vasc Res, 2014, 51(2): 118-131.
[12]
Nold MF,Nold-Petry CA,Zepp JA, et al.IL-37 is a fundamental inhibitor of innate immunity[J]. Nat Immunol, 2010, 11(11): 1014-1022.
[13]
Yu K,Min X,Lin Y, et al.Increased IL-37 concentrations in patients with arterial calcification[J]. Clinica Chimica Acta, 2016(461): 19-24.
[14]
Tintut Y,Patel J,Parhami F, et al.Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway[J]. Circulation, 2000, 102(21): 2636-2642.
[15]
Nadra I,Mason JC,Philippidis P, et al.Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways:a vicious cycle of inflammation and arterial calcification?[J]. Circ Res, 2005, 96(12): 1248-1256.
[16]
Dellegrottaglie S,Sanz J,Rajagopalan S, et al.Molecular determinants of vascular calcification:a bench to bedside view[J]. Curr Mol Med, 2006, 6(5): 515-524.
[17]
Lee HL,Woo KM,Ryoo HM, et al.Tumor necrosis factor-alpha increases alkaline phosphatase expression in vascular smooth muscle cells via MSX2 induction[J]. Biochem Biophys Res Commun, 2010, 391(1): 1087-1092.
[18]
Shao JS,Cheng SL,Pingsterhaus JM, et al.Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals[J]. J Clin Invest, 2005, 115(5): 1210-1220.
[19]
Al-Aly Z,Shao JS,Lai CF, et al.Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr-/-mice[J]. Arterioscler Thromb Vasc Biol, 2007, 27(12): 2589-2596.
[20]
Son BK,Kozaki K,Iijima K, et al.Statins protect human aortic smooth muscle cells from inorganic phosphate-induced calcification by restoring Gas6-Axl survival pathway[J]. Circ Res, 2006, 98(8): 1024-1031.
[21]
Son BK,Akishita M,Iijima K, et al.Adiponectin antagonizes stimulatory effect of tumor necrosis factor-alpha on vascular smooth muscle cell calcification:regulation of growth arrest-specific gene 6-mediated survival pathway by adenosine 5'-monophosphate-activated protein kinase[J]. Endocrinology, 2008, 149(4): 1646-1653.
[22]
Masuda M,Miyazaki-Anzai S,Levi M, et al.PERK-eIF2alpha-ATF4-CHOP signaling contributes to TNFalpha-induced vascular calcification[J]. J Am Heart Assoc, 2013, 2(5): e000238.
[23]
Galvin KM,Donovan MJ,Lynch CA, et al.A role for smad6 in development and homeostasis of the cardiovascular system[J]. Nat Genet, 2000, 24(2): 171-174.
[24]
Libby P,Ridker PM,Hansson GK, et al.Progress and challenges in translating the biology of atherosclerosis[J]. Nature, 2011, 473(7347): 317-325.
[25]
Ishimura E,Okuno S,Kitatani K, et al.C-reactive protein is a significant predictor of vascular calcification of both aorta and hand arteries[J]. Semin Nephrol, 2004, 24(5): 408-412.
[26]
Couchourel D,Aubry I,Delalandre A, et al.Altered mineralization of human osteoarthritic osteoblasts is attributable to abnormal type I collagen production[J]. Arthritis Rheum, 2009, 60(5): 1438-1450.
[27]
Qin X,Corriere MA,Matrisian LM, et al.Matrix metalloproteinase inhibition attenuates aortic calcification[J]. Arterioscler Thromb Vasc Biol, 2006, 26(7): 1510-1516.
[28]
彭朝胜,曹悦鞍. 胎球蛋白-A与动脉钙化[J]. 海军总医院学报, 2010(01): 29-32.
[29]
Cheng SL,Shao JS,Charlton-Kachigian N, et al.MSX2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors[J]. J Biol Chem, 2003, 278(46): 45969-45977.
[30]
Liberman M,Johnson RC,Handy DE, et al.Bone morphogenetic protein-2 activates NADPH oxidase to increase endoplasmic reticulum stress and human coronary artery smooth muscle cell calcification[J]. Biochem Biophys Res Commun, 2011, 413(3): 436-441.
[31]
Cai J,Pardali E,Sanchez-Duffhues G, et al.BMP signaling in vascular diseases[J]. FEBS Lett, 2012, 586(14): 1993-2002.
[32]
Yao Y,Bennett BJ,Wang X, et al.Inhibition of bone morphogenetic proteins protects against atherosclerosis and vascular calcification[J]. Circ Res, 2010, 107(4): 485-494.
[33]
Li Y,Messina C,Bendaoud M, et al.Adaptive immune response in osteoclastic bone resorption induced by orally administered aggregatibacter actinomycetemcomitans in a rat model of periodontal disease[J]. Mol Oral Microbiol, 2010, 25(4): 275-292.
[34]
Buendía P,Montes dA,Madueño JA, et al.Endothelial microparticles mediate inflammation-induced vascular calcification[J]. FASEB J, 2015, 29(1): 173-181.
[35]
Zhao G,Xu MJ,Zhao MM, et al.Activation of nuclear factor-kappa B accelerates vascular calcification by inhibiting ankylosis protein homolog expression[J]. Kidney Int, 2012, 82(1): 34-44.
[36]
Kageyama A,Matsui H,Ohta M, et al.Palmitic acid induces osteoblastic differentiation in vascular smooth muscle cells through ACSL3 and NF-kappaB, novel targets of eicosapentaenoic acid[J]. PLoS ONE, 2013, 8(6): e68197.
[37]
Zhan JK,Tan P,Wang YJ, et al.Exenatide can inhibit calcification of human VSMCs through the NF-kappaB/RANKL signaling pathway[J]. Cardiovasc Diabetol, 2014, 13: 153.
[38]
Ma YY,Sun L,Chen XJ, et al.Vinpocetine attenuates the osteoblastic differentiation of vascular smooth muscle cells[J]. PLoS ONE, 2016, 11(9): e0162295.
[39]
Zewinger S,Schumann T,Fliser D, et al.Innate immunity in CKD-associated vascular diseases[J]. Nephrol Dial Transplant, 2016, 31(11): 1813-1821.
[40]
徐明江. 线粒体氧化应激和细胞自噬在肾衰后血管钙化中的作用[C]. 中国生理学会第24届全国会员代表大会暨生理学学术大会.2014, 中国上海.
[41]
Kurts C,Panzer U,Anders HJ, et al.The immune system and kidney disease:basic concepts and clinical implications[J]. Nat Rev Immunol, 2013, 13(10): 738-753.
[42]
Leemans JC,Kors L,Anders HJ, et al.Pattern recognition receptors and the inflammasome in kidney disease[J]. Nat Rev Nephrol, 2014, 10(7): 398-414.
[43]
Pazar B,Ea HK,Narayan S, et al.Basic calcium phosphate crystals induce monocyte/macrophage IL-1beta secretion through the NLRP3 inflammasome in vitro[J]. J Immunol, 2011, 186(4): 2495-2502.
[44]
Yun TJ,Chaudhary PM,Shu GL, et al.OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40[J]. J Immunol, 1998, 161(11): 6113-6121.
[45]
Osako MK,Nakagami H,Koibuchi N, et al.Estrogen inhibits vascular calcification via vascular RANKL system:common mechanism of osteoporosis and vascular calcification[J]. Circ Res, 2010, 107(4): 466-475.
[46]
Deuell KA,Callegari A,Giachelli CM, et al.RANKL enhances macrophage paracrine pro-calcific activity in high phosphate-treated smooth muscle cells:dependence on IL-6 and TNF-alpha[J]. J Vasc Res, 2012, 49(6): 510-521.
[47]
Nie B,Zhou SQ,Fang X, et al.The function and meaning of receptor activator of NF-kappaB ligand in arterial calcification[J]. J Huazhong Univ Sci Technolog Med Sci, 2015, 35(5): 666-671.
[48]
Gochuico BR,Zhang J,Ma BY, et al.TRAIL expression in vascular smooth muscle[J]. Am J Physiol Lung Cell Mol Physiol, 2000, 278(5): 1045-1050.
[49]
Schoppet M,Alfakhri N,Franke FE, et al.Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-κB ligand in mönckeberg′s sclerosis and atherosclerosis[J]. J Clin Endocrinol Metab, 2004, 89(8): 4104-4112.
[1] 武壮壮, 张晓娟, 史泽洪, 史瑶, 原韶玲. 超声联合乳腺X线摄影及PR、Her-2预测高级别与中低级别乳腺导管原位癌的价值[J]. 中华医学超声杂志(电子版), 2023, 20(06): 631-635.
[2] 伍秋苑, 陈佩贤, 邓裕华, 何添成, 周丹. 肠道微生物在乳腺癌中的研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 362-365.
[3] 周婉丽, 钱铮, 李喆. 槐耳在乳腺癌免疫治疗中的研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 369-371.
[4] 姚咏明. 如何精准评估烧伤脓毒症患者免疫状态[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 552-552.
[5] 王得晨, 杨康, 杨自杰, 归明彬, 屈莲平, 张小凤, 高峰. 结直肠癌微卫星稳定状态和程序性死亡、吲哚胺2,3-双加氧酶关系的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 462-465.
[6] 钱龙, 陆晓峰, 王行舟, 杜峻峰, 沈晓菲, 管文贤. 神经系统调控胃肠道肿瘤免疫应答研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 86-89.
[7] 陈大敏, 曹晓刚, 曹能琦. 肥胖对胃癌患者手术治疗效果的影响研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 651-653.
[8] 王可, 范彬, 李多富, 刘奎. 两种疝囊残端处理方法在经腹腹膜前腹股沟疝修补术中的疗效比较[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 692-696.
[9] 关旭, 王锡山. 基于外科与免疫视角思考结直肠癌区域淋巴结处理的功与过[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 448-452.
[10] 胡宝茹, 尚乃舰, 高迪. 中晚期肝细胞癌的DCE-MRI及DWI表现与免疫治疗预后的相关性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 399-403.
[11] 梁文龙, 曹杰, 黄庆, 林泳, 黄红丽, 杨平, 李冠炜, 胡鹤. 信迪利单抗联合瑞戈非尼治疗晚期结直肠癌的疗效与安全性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 409-413.
[12] 屈霄, 王靓, 陆萍, 何斌, 孙敏. 外周血炎症因子及肠道菌群特征与活动性溃疡性结肠炎患者病情的相关性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 466-470.
[13] 岳瑞雪, 孔令欣, 郝鑫, 杨进强, 韩猛, 崔国忠, 王建军, 张志生, 孔凡庭, 张维, 何文博, 李现桥, 周新平, 徐东宏, 胡崇珠. 乳腺癌HER2蛋白表达水平预测新辅助治疗疗效的真实世界研究[J]. 中华临床医师杂志(电子版), 2023, 17(07): 765-770.
[14] 符梅沙, 周玉华, 李慧, 薛春颜. 淋巴细胞免疫治疗对复发性流产患者外周血T淋巴细胞亚群分布与PD1/PD-L1表达的影响及意义[J]. 中华临床医师杂志(电子版), 2023, 17(06): 726-730.
[15] 王丁然, 迟洪滨. 自身免疫甲状腺炎对子宫内膜异位症患者胚胎移植结局的影响[J]. 中华临床医师杂志(电子版), 2023, 17(06): 682-688.
阅读次数
全文


摘要